Glenmark Pharmaceuticals Sees 4,911 Contracts in Rs 1800 Puts Amid Stock Decline

Glenmark Pharmaceuticals Ltd. has emerged as one of the most active stocks in the options market today, particularly in the put options segment. The company, operating in the Pharmaceuticals & Biotechnology industry with a market capitalization of Rs 53,392 crore, has seen significant trading activity in its put options expiring on November 25, 2025.
Among the notable trades, the put option with a strike price of Rs 1800 recorded the highest volume, with 4,911 contracts traded and a turnover of approximately Rs 323.94 lakh. Following closely, the Rs 1840 strike price put saw 4,013 contracts traded, generating a turnover of Rs 455.83 lakh. Other strike prices, including Rs 1780, Rs 1820, and Rs 1860, also experienced substantial trading volumes, with respective turnovers of Rs 93.76 lakh, Rs 354.78 lakh, and Rs 500.45 lakh.

Despite this activity, Glenmark's stock has underperformed its sector by 3.21%, opening down 2.14% today and reaching an intraday low of Rs 1810, reflecting a one-day return of -0.58%. The stock's performance has shown a trend reversal after three consecutive days of gains, with trading volumes indicating rising investor participation. The liquidity remains robust, supporting trades of up to Rs 4.81 crore.

In summary, Glenmark Pharmaceuticals is witnessing heightened activity in its put options, reflecting a dynamic trading environment amid recent stock performance challenges.